First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody

A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, an...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 13; no. 1; pp. 1219 - 15
Main Authors Beckford-Vera, Denis R., Flavell, Robert R., Seo, Youngho, Martinez-Ortiz, Enrique, Aslam, Maya, Thanh, Cassandra, Fehrman, Emily, Pardons, Marion, Kumar, Shreya, Deitchman, Amelia N., Ravanfar, Vahid, Schulte, Brailee, Wu, I-Wei Katherine, Pan, Tony, Reeves, Jacqueline D., Nixon, Christopher C., Iyer, Nikita S., Torres, Leonel, Munter, Sadie E., Hyunh, Tony, Petropoulos, Christos J., Hoh, Rebecca, Franc, Benjamin L., Gama, Lucio, Koup, Richard A., Mascola, John R., Chomont, Nicolas, Deeks, Steven G., VanBrocklin, Henry F., Henrich, Timothy J.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 09.03.2022
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text
ISSN2041-1723
2041-1723
DOI10.1038/s41467-022-28727-5

Cover

Abstract A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89 Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89 Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia ( N  = 5) and on suppressive ART ( N  = 5) compared to uninfected controls ( N  = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases. Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody, 89 Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions.
AbstractList A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89 Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89 Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia ( N  = 5) and on suppressive ART ( N  = 5) compared to uninfected controls ( N  = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases.
Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody, 89Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions.
A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89 Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89 Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia ( N  = 5) and on suppressive ART ( N  = 5) compared to uninfected controls ( N  = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases. Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody, 89 Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions.
A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (N = 5) and on suppressive ART (N = 5) compared to uninfected controls (N = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases.Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly neutralizing antibody, 89Zr-VRC01, and show that PET tracer lymph node uptake positively correlates with HIV protein levels measured directly from cells obtained from these tissues. This strategy may allow non-invasive characterization of residual HIV infection in the setting of therapeutic interventions.
A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (N = 5) and on suppressive ART (N = 5) compared to uninfected controls (N = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases.A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells that establish a long-lived viral reservoir. HIV largely resides in anatomical regions that are inaccessible to routine sampling, however, and non-invasive methods to understand the longitudinal tissue-wide burden of HIV persistence are urgently needed. Positron emission tomography (PET) imaging is a promising strategy to identify and characterize the tissue-wide burden of HIV. Here, we assess the efficacy of using immunoPET imaging to characterize HIV reservoirs and identify anatomical foci of persistent viral transcriptional activity using a radiolabeled HIV Env-specific broadly neutralizing antibody, 89Zr-VRC01, in HIV-infected individuals with detectable viremia and on suppressive ART compared to uninfected controls (NCT03729752). We also assess the relationship between PET tracer uptake in tissues and timing of ART initiation and direct HIV protein expression in CD4 T cells obtained from lymph node biopsies. We observe significant increases in 89Zr-VRC01 uptake in various tissues (including lymph nodes and gut) in HIV-infected individuals with detectable viremia (N = 5) and on suppressive ART (N = 5) compared to uninfected controls (N = 5). Importantly, PET tracer uptake in inguinal lymph nodes in viremic and ART-suppressed participants significantly and positively correlates with HIV protein expression measured directly in tissue. Our strategy may allow non-invasive longitudinal characterization of residual HIV infection and lays the framework for the development of immunoPET imaging in a variety of other infectious diseases.
ArticleNumber 1219
Author Munter, Sadie E.
Schulte, Brailee
Seo, Youngho
Martinez-Ortiz, Enrique
Reeves, Jacqueline D.
Flavell, Robert R.
Koup, Richard A.
Wu, I-Wei Katherine
Nixon, Christopher C.
Henrich, Timothy J.
Thanh, Cassandra
Hyunh, Tony
Petropoulos, Christos J.
Deeks, Steven G.
Chomont, Nicolas
Franc, Benjamin L.
Mascola, John R.
Fehrman, Emily
Deitchman, Amelia N.
Torres, Leonel
Aslam, Maya
Pardons, Marion
Kumar, Shreya
Pan, Tony
Gama, Lucio
Beckford-Vera, Denis R.
Ravanfar, Vahid
VanBrocklin, Henry F.
Hoh, Rebecca
Iyer, Nikita S.
Author_xml – sequence: 1
  givenname: Denis R.
  surname: Beckford-Vera
  fullname: Beckford-Vera, Denis R.
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 2
  givenname: Robert R.
  orcidid: 0000-0002-8694-1199
  surname: Flavell
  fullname: Flavell, Robert R.
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 3
  givenname: Youngho
  orcidid: 0000-0001-5908-6636
  surname: Seo
  fullname: Seo, Youngho
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 4
  givenname: Enrique
  surname: Martinez-Ortiz
  fullname: Martinez-Ortiz, Enrique
  organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco
– sequence: 5
  givenname: Maya
  surname: Aslam
  fullname: Aslam, Maya
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 6
  givenname: Cassandra
  orcidid: 0000-0001-6458-3469
  surname: Thanh
  fullname: Thanh, Cassandra
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 7
  givenname: Emily
  surname: Fehrman
  fullname: Fehrman, Emily
  organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco
– sequence: 8
  givenname: Marion
  surname: Pardons
  fullname: Pardons, Marion
  organization: Department of Microbiology, Infectiology and Immunology, Centre de Recherche du CHUM, Université de Montréal
– sequence: 9
  givenname: Shreya
  surname: Kumar
  fullname: Kumar, Shreya
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 10
  givenname: Amelia N.
  orcidid: 0000-0002-4722-463X
  surname: Deitchman
  fullname: Deitchman, Amelia N.
  organization: Department of Clinical Pharmacy, University of California
– sequence: 11
  givenname: Vahid
  surname: Ravanfar
  fullname: Ravanfar, Vahid
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 12
  givenname: Brailee
  surname: Schulte
  fullname: Schulte, Brailee
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 13
  givenname: I-Wei Katherine
  surname: Wu
  fullname: Wu, I-Wei Katherine
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 14
  givenname: Tony
  surname: Pan
  fullname: Pan, Tony
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 15
  givenname: Jacqueline D.
  surname: Reeves
  fullname: Reeves, Jacqueline D.
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 16
  givenname: Christopher C.
  surname: Nixon
  fullname: Nixon, Christopher C.
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 17
  givenname: Nikita S.
  surname: Iyer
  fullname: Iyer, Nikita S.
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 18
  givenname: Leonel
  surname: Torres
  fullname: Torres, Leonel
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 19
  givenname: Sadie E.
  surname: Munter
  fullname: Munter, Sadie E.
  organization: Division of Experimental Medicine, University of California San Francisco
– sequence: 20
  givenname: Tony
  surname: Hyunh
  fullname: Hyunh, Tony
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 21
  givenname: Christos J.
  orcidid: 0000-0001-5496-8090
  surname: Petropoulos
  fullname: Petropoulos, Christos J.
  organization: Monogram Biosciences, Inc., Laboratory Corporation of America, South San Francisco
– sequence: 22
  givenname: Rebecca
  surname: Hoh
  fullname: Hoh, Rebecca
  organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco
– sequence: 23
  givenname: Benjamin L.
  surname: Franc
  fullname: Franc, Benjamin L.
  organization: Department of Radiology, Stanford University
– sequence: 24
  givenname: Lucio
  surname: Gama
  fullname: Gama, Lucio
  organization: Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health
– sequence: 25
  givenname: Richard A.
  surname: Koup
  fullname: Koup, Richard A.
  organization: Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health
– sequence: 26
  givenname: John R.
  surname: Mascola
  fullname: Mascola, John R.
  organization: Vaccine Research Center, National Institute for Allergy and Infectious Diseases, National Institutes of Health
– sequence: 27
  givenname: Nicolas
  orcidid: 0000-0001-9747-5018
  surname: Chomont
  fullname: Chomont, Nicolas
  organization: Department of Microbiology, Infectiology and Immunology, Centre de Recherche du CHUM, Université de Montréal
– sequence: 28
  givenname: Steven G.
  orcidid: 0000-0001-6371-747X
  surname: Deeks
  fullname: Deeks, Steven G.
  organization: Division of HIV, Infectious Diseases and Global Medicine, University of California San Francisco
– sequence: 29
  givenname: Henry F.
  orcidid: 0000-0003-2849-0841
  surname: VanBrocklin
  fullname: VanBrocklin, Henry F.
  email: Henry.Vanbrocklin@ucsf.edu
  organization: Department of Radiology and Biomedical Imaging, University of California San Francisco
– sequence: 30
  givenname: Timothy J.
  orcidid: 0000-0002-6684-0622
  surname: Henrich
  fullname: Henrich, Timothy J.
  email: Timothy.Henrich@ucsf.edu
  organization: Division of Experimental Medicine, University of California San Francisco
BookMark eNp9Uk1v1TAQtFARLaV_gFMkLlxM_Rk7FyT01NInVQKh0gMXy3ac1E-JXeyk0uPX4zRFtD3UF6-8M7O7nn0LDkIMDoD3GH3CiMrTzDCrBUSEQCIFEZC_AkcEMQyxIPTgUXwITnLeoXJogyVjb8Ah5aRmnDdHYHfuU56gD_BmHnWo_DjOIX4_uyqR7n3oq9hVF9triCsfOmcnH0M15yUhm18JDtq4wbXV9Y8NwpVJUbfDvgpunpIe_J8Fp8PkTWz378DrTg_ZnTzcx-Dn-dnV5gJefvu63Xy5hJZjOsGOIoYEJ4TWzDDRyMYIwzTqSmwZcwijjrYNwowS40hLKDfCtcY0THJnCT0G21W3jXqnblMZJO1V1F7dP8TUK50mbwenGNEYOyRr1HbMYFLqYc0Y7bTshLOmaH1etW5nM7rWurDM9UT0aSb4G9XHOyUbJCjnReDjg0CKv2eXJzX6bN0w6ODinBWpqSweFmsK9MMz6C7OKZSvWlCiZlJgUVByRdkUc06uU9ZPerGl1PeDwkgt-6HW_VBFW93vh1p6Ic-o_-Z4kURXUi7g0Lv0v6sXWH8B3TjMQQ
CitedBy_id crossref_primary_10_3390_v15051126
crossref_primary_10_1093_pnasnexus_pgad446
crossref_primary_10_1093_infdis_jiad247
crossref_primary_10_1007_s00259_025_07110_8
crossref_primary_10_1093_infdis_jiad223
crossref_primary_10_3389_fnume_2024_1360710
crossref_primary_10_1038_s41590_024_01948_0
crossref_primary_10_1016_j_ijpharm_2024_123795
crossref_primary_10_3390_biomedicines11020617
crossref_primary_10_1016_j_trac_2023_117470
crossref_primary_10_1128_cmr_00152_22
crossref_primary_10_1007_s12149_024_01979_5
crossref_primary_10_1038_s41467_024_54580_9
crossref_primary_10_1038_s44303_024_00056_w
crossref_primary_10_1016_j_isci_2025_111795
crossref_primary_10_1080_14787210_2023_2184345
crossref_primary_10_7554_eLife_89837
crossref_primary_10_1089_aid_2022_0180
crossref_primary_10_1186_s40658_024_00666_8
crossref_primary_10_7554_eLife_89837_3
crossref_primary_10_1093_infdis_jiad079
crossref_primary_10_3389_fmed_2022_979756
crossref_primary_10_1053_j_semnuclmed_2023_03_001
crossref_primary_10_1371_journal_ppat_1012888
crossref_primary_10_1021_acsinfecdis_2c00573
crossref_primary_10_3390_ijms24054374
crossref_primary_10_1097_COH_0000000000000840
crossref_primary_10_3389_fmed_2023_1178528
Cites_doi 10.2967/jnumed.112.108530
10.1097/00126334-200101010-00001
10.1002/psp4.12224
10.1038/nm.4411
10.2967/jnumed.115.155309
10.1097/RLU.0000000000002229
10.1053/j.sult.2010.10.001
10.1128/JVI.00754-11
10.1073/pnas.1414148111
10.1056/NEJMoa1608243
10.1007/s11307-019-01363-0
10.1038/387183a0
10.2967/jnumed.117.190736
10.1128/JVI.76.7.3522-3533.2002
10.1128/JVI.00734-12
10.1371/journal.pone.0193832
10.1126/science.278.5341.1295
10.1038/mi.2008.23
10.1186/s13550-016-0208-5
10.1093/infdis/jiv504
10.1016/j.str.2015.07.020
10.1002/jlcr.3605
10.1097/QAD.0b013e3280117204
10.1038/nm880
10.1021/acs.chemrev.9b00738
10.1073/pnas.122696599
10.1038/nmeth.3320
10.1086/656722
10.1073/pnas.1414926112
10.2967/jnumed.118.224568
10.1038/nprot.2010.13
10.1126/science.1192819
10.1086/654816
10.1007/s40495-018-0142-5
10.1007/s00259-019-04307-6
10.1007/s00259-009-1263-1
10.1126/science.1187659
10.1016/j.ebiom.2021.103252
10.1371/journal.pmed.1002435
10.1038/mi.2017.112
10.1371/journal.ppat.1007619
10.3389/fimmu.2019.02077
10.1126/scitranslmed.aad5752
10.1097/01.qai.0000230524.71717.14
10.1172/JCI134815
10.3791/52521
10.7326/M14-1027
10.1128/JVI.01344-18
10.7554/eLife.46916
10.2967/jnumed.117.207670
ContentType Journal Article
Copyright The Author(s) 2022
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022. The Author(s).
Copyright_xml – notice: The Author(s) 2022
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
SOI
7X8
5PM
DOA
DOI 10.1038/s41467-022-28727-5
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest : Biological Science Collection journals [unlimited simultaneous users]
ProQuest Central
Technology Collection
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Proquest Medical Database
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef



Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 15
ExternalDocumentID oai_doaj_org_article_42a11e0860df4b12b471a443fa8f7ecb
PMC8907355
10_1038_s41467_022_28727_5
GrantInformation_xml – fundername: U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
– fundername: U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  grantid: UM1AI126611; R01AI152932
  funderid: https://doi.org/10.13039/100000060
– fundername: amfAR, The Foundation for AIDS Research (amfAR)
  grantid: Institute for Cure Research
  funderid: https://doi.org/10.13039/100001117
– fundername: ;
– fundername: ;
  grantid: Institute for Cure Research
– fundername: ;
  grantid: UM1AI126611; R01AI152932
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AARCD
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
SOI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c513t-f30407522364b47989b7b4a0f479c44e010f3d901432be2d235b7edbb9485ec23
IEDL.DBID M48
ISSN 2041-1723
IngestDate Wed Aug 27 01:32:17 EDT 2025
Thu Aug 21 18:33:56 EDT 2025
Fri Sep 05 02:43:05 EDT 2025
Wed Aug 13 11:25:08 EDT 2025
Thu Apr 24 22:53:03 EDT 2025
Tue Jul 01 04:17:46 EDT 2025
Fri Feb 21 02:38:52 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c513t-f30407522364b47989b7b4a0f479c44e010f3d901432be2d235b7edbb9485ec23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6684-0622
0000-0001-9747-5018
0000-0001-5908-6636
0000-0001-5496-8090
0000-0002-4722-463X
0000-0001-6371-747X
0000-0002-8694-1199
0000-0001-6458-3469
0000-0003-2849-0841
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-022-28727-5
PMID 35264559
PQID 2637648717
PQPubID 546298
PageCount 15
ParticipantIDs doaj_primary_oai_doaj_org_article_42a11e0860df4b12b471a443fa8f7ecb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8907355
proquest_miscellaneous_2638022039
proquest_journals_2637648717
crossref_citationtrail_10_1038_s41467_022_28727_5
crossref_primary_10_1038_s41467_022_28727_5
springer_journals_10_1038_s41467_022_28727_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-03-09
PublicationDateYYYYMMDD 2022-03-09
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-09
  day: 09
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Siliciano (CR3) 2003; 9
Gilbert (CR18) 2010; 202
Chun (CR14) 2014; 111
Yukl (CR31) 2010; 202
McMahon (CR35) 2021; 65
Ryman, Meibohm (CR43) 2017; 6
Wu (CR49) 2010; 329
McKnight, Viola-Villegas (CR39) 2018; 61
CR33
CR32
Rothenberger (CR36) 2015; 112
Nilsson (CR27) 2007; 21
Ouyang (CR22) 2018; 43
Perk (CR46) 2010; 37
Boktor, Walker, Stacey, Gledhill, Pitman (CR26) 2013; 54
Vosjan (CR45) 2010; 5
Bar (CR9) 2016; 375
Mayer (CR10) 2017; 14
Finzi (CR2) 1997; 278
Kinahan, Fletcher (CR19) 2010; 31
Diao, Meibohm (CR44) 2018; 4
Lynch (CR11) 2015; 7
Wei (CR37) 2020; 120
CR5
Butof (CR21) 2015; 56
Henrich, Hsue, VanBrocklin (CR8) 2019; 10
Jauw (CR38) 2019; 60
Lineberger, Danzeisen, Hazuda, Simon, Miller (CR41) 2002; 76
Sheth (CR29) 2008; 1
Estes (CR4) 2017; 23
Hofheinz (CR25) 2019; 46
Santangelo (CR6) 2015; 12
Lynch (CR17) 2012; 86
Beckford Vera (CR47) 2018; 13
Beckford-Vera (CR48) 2020; 22
CR16
CR15
Zhou (CR12) 2010; 329
Talal (CR30) 2001; 26
CR50
Li (CR13) 2011; 85
Hofheinz, Apostolova, Oehme, Kotzerke, van den Hoff (CR23) 2017; 58
Poles (CR28) 2006; 43
Pardons (CR34) 2019; 15
Hofheinz (CR20) 2016; 6
Santangelo (CR7) 2018; 11
Chun (CR1) 1997; 387
Lee, de Val, Lyumkis, Ward (CR42) 2015; 23
CR24
Henrich (CR51) 2016; 213
Miranda, Schaefer, Kupfer, Hu, Franzusoff (CR40) 2002; 99
JD Siliciano (28727_CR3) 2003; 9
RR Boktor (28727_CR26) 2013; 54
MK Rothenberger (28727_CR36) 2015; 112
28727_CR5
JH McMahon (28727_CR35) 2021; 65
28727_CR24
YWS Jauw (28727_CR38) 2019; 60
X Wu (28727_CR49) 2010; 329
J Nilsson (28727_CR27) 2007; 21
RM Lynch (28727_CR11) 2015; 7
TW Chun (28727_CR1) 1997; 387
KJ Bar (28727_CR9) 2016; 375
TJ Henrich (28727_CR51) 2016; 213
SA Yukl (28727_CR31) 2010; 202
JT Ryman (28727_CR43) 2017; 6
P Gilbert (28727_CR18) 2010; 202
PJ Santangelo (28727_CR7) 2018; 11
DR Beckford Vera (28727_CR47) 2018; 13
F Hofheinz (28727_CR25) 2019; 46
JD Estes (28727_CR4) 2017; 23
28727_CR33
28727_CR32
ML Ouyang (28727_CR22) 2018; 43
PE Kinahan (28727_CR19) 2010; 31
MA Poles (28727_CR28) 2006; 43
L Diao (28727_CR44) 2018; 4
M Pardons (28727_CR34) 2019; 15
TW Chun (28727_CR14) 2014; 111
DR Beckford-Vera (28727_CR48) 2020; 22
RM Lynch (28727_CR17) 2012; 86
W Wei (28727_CR37) 2020; 120
LR Perk (28727_CR46) 2010; 37
KH Mayer (28727_CR10) 2017; 14
MJ Vosjan (28727_CR45) 2010; 5
AH Talal (28727_CR30) 2001; 26
R Butof (28727_CR21) 2015; 56
T Zhou (28727_CR12) 2010; 329
LR Miranda (28727_CR40) 2002; 99
Y Li (28727_CR13) 2011; 85
TJ Henrich (28727_CR8) 2019; 10
28727_CR16
28727_CR15
F Hofheinz (28727_CR23) 2017; 58
BN McKnight (28727_CR39) 2018; 61
JE Lineberger (28727_CR41) 2002; 76
JH Lee (28727_CR42) 2015; 23
PJ Santangelo (28727_CR6) 2015; 12
28727_CR50
D Finzi (28727_CR2) 1997; 278
PM Sheth (28727_CR29) 2008; 1
F Hofheinz (28727_CR20) 2016; 6
References_xml – volume: 54
  start-page: 677
  year: 2013
  end-page: 682
  ident: CR26
  article-title: Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.112.108530
– volume: 26
  start-page: 1
  year: 2001
  end-page: 7
  ident: CR30
  article-title: Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue
  publication-title: J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/00126334-200101010-00001
– ident: CR16
– volume: 6
  start-page: 576
  year: 2017
  end-page: 588
  ident: CR43
  article-title: Pharmacokinetics of monoclonal antibodies
  publication-title: CPT Pharmacomet. Syst. Pharm.
  doi: 10.1002/psp4.12224
– volume: 23
  start-page: 1271
  year: 2017
  end-page: 1276
  ident: CR4
  article-title: Defining total-body AIDS-virus burden with implications for curative strategies
  publication-title: Nat. Med.
  doi: 10.1038/nm.4411
– volume: 56
  start-page: 1150
  year: 2015
  end-page: 1156
  ident: CR21
  article-title: Prognostic value of pretherapeutic tumor-to-blood standardized uptake ratio in patients with esophageal carcinoma
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.155309
– volume: 43
  start-page: 715
  year: 2018
  end-page: 720
  ident: CR22
  article-title: Prediction of occult lymph node metastasis using tumor-to-blood standardized uptake ratio and metabolic parameters in clinical N0 lung adenocarcinoma
  publication-title: Clin. Nucl. Med.
  doi: 10.1097/RLU.0000000000002229
– volume: 31
  start-page: 496
  year: 2010
  end-page: 505
  ident: CR19
  article-title: Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy
  publication-title: Semin. Ultrasound CT MR
  doi: 10.1053/j.sult.2010.10.001
– volume: 85
  start-page: 8954
  year: 2011
  end-page: 8967
  ident: CR13
  article-title: Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01
  publication-title: J. Virol.
  doi: 10.1128/JVI.00754-11
– volume: 111
  start-page: 13151
  year: 2014
  end-page: 13156
  ident: CR14
  article-title: Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1414148111
– volume: 375
  start-page: 2037
  year: 2016
  end-page: 2050
  ident: CR9
  article-title: Effect of HIV antibody VRC01 on viral rebound after treatment interruption
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1608243
– volume: 22
  start-page: 105
  year: 2020
  end-page: 114
  ident: CR48
  article-title: PET/CT imaging of human TNFalpha using [(89)Zr]certolizumab pegol in a transgenic preclinical model of rheumatoid arthritis
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-019-01363-0
– volume: 387
  start-page: 183
  year: 1997
  end-page: 188
  ident: CR1
  article-title: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
  publication-title: Nature
  doi: 10.1038/387183a0
– volume: 58
  start-page: 1770
  year: 2017
  end-page: 1775
  ident: CR23
  article-title: Test-retest variability in lesion SUV and lesion SUR in (18)F-FDG PET: an analysis of data from two prospective multicenter trials
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.117.190736
– volume: 76
  start-page: 3522
  year: 2002
  end-page: 3533
  ident: CR41
  article-title: Altering expression levels of human immunodeficiency virus type 1 gp120-gp41 affects efficiency but not kinetics of cell-cell fusion
  publication-title: J. Virol.
  doi: 10.1128/JVI.76.7.3522-3533.2002
– ident: CR15
– volume: 86
  start-page: 7588
  year: 2012
  end-page: 7595
  ident: CR17
  article-title: The development of CD4 binding site antibodies during HIV-1 infection
  publication-title: J. Virol.
  doi: 10.1128/JVI.00734-12
– volume: 13
  start-page: e0193832
  year: 2018
  ident: CR47
  article-title: Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0193832
– ident: CR50
– volume: 278
  start-page: 1295
  year: 1997
  end-page: 1300
  ident: CR2
  article-title: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
  publication-title: Science
  doi: 10.1126/science.278.5341.1295
– ident: CR32
– volume: 1
  start-page: 382
  year: 2008
  end-page: 388
  ident: CR29
  article-title: Immune reconstitution in the sigmoid colon after long-term HIV therapy
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2008.23
– volume: 6
  year: 2016
  ident: CR20
  article-title: Comparative evaluation of SUV, tumor-to-blood standard uptake ratio (SUR), and dual time point measurements for assessment of the metabolic uptake rate in FDG PET
  publication-title: EJNMMI Res.
  doi: 10.1186/s13550-016-0208-5
– volume: 213
  start-page: 766
  year: 2016
  end-page: 770
  ident: CR51
  article-title: CCR5-Delta32 heterozygosity, HIV-1 reservoir size, and lymphocyte activation in individuals receiving long-term suppressive antiretroviral therapy
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiv504
– ident: CR5
– volume: 23
  start-page: 1943
  year: 2015
  end-page: 1951
  ident: CR42
  article-title: Model building and refinement of a natively glycosylated HIV-1 Env protein by high-resolution cryoelectron microscopy
  publication-title: Structure
  doi: 10.1016/j.str.2015.07.020
– volume: 61
  start-page: 727
  year: 2018
  end-page: 738
  ident: CR39
  article-title: (89) Zr-ImmunoPET companion diagnostics and their impact in clinical drug development
  publication-title: J. Label. Comp. Radiopharm.
  doi: 10.1002/jlcr.3605
– volume: 21
  start-page: 565
  year: 2007
  end-page: 574
  ident: CR27
  article-title: Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection
  publication-title: Aids
  doi: 10.1097/QAD.0b013e3280117204
– volume: 9
  start-page: 727
  year: 2003
  end-page: 728
  ident: CR3
  article-title: Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4(+) T cells
  publication-title: Nat. Med.
  doi: 10.1038/nm880
– ident: CR33
– volume: 120
  start-page: 3787
  year: 2020
  end-page: 3851
  ident: CR37
  article-title: ImmunoPET: concept, design, and applications
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.9b00738
– volume: 99
  start-page: 8031
  year: 2002
  end-page: 8036
  ident: CR40
  article-title: Cell surface expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing regulated secretory granules
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.122696599
– volume: 12
  start-page: 427
  year: 2015
  end-page: 432
  ident: CR6
  article-title: Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3320
– volume: 202
  start-page: 1553
  year: 2010
  end-page: 1561
  ident: CR31
  article-title: Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy
  publication-title: J. Infect. Dis.
  doi: 10.1086/656722
– volume: 112
  start-page: E1126
  year: 2015
  end-page: E1134
  ident: CR36
  article-title: Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1414926112
– volume: 60
  start-page: 1825
  year: 2019
  end-page: 1832
  ident: CR38
  article-title: (89)Zr-Immuno-PET: toward a noninvasive clinical tool to measure target engagement of therapeutic antibodies in vivo
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.118.224568
– volume: 5
  start-page: 739
  year: 2010
  end-page: 743
  ident: CR45
  article-title: Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2010.13
– volume: 329
  start-page: 811
  year: 2010
  end-page: 817
  ident: CR12
  article-title: Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01
  publication-title: Science
  doi: 10.1126/science.1192819
– volume: 202
  start-page: 595
  year: 2010
  end-page: 605
  ident: CR18
  article-title: Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine
  publication-title: J. Infect. Dis.
  doi: 10.1086/654816
– volume: 4
  start-page: 285
  year: 2018
  end-page: 291
  ident: CR44
  article-title: Pharmacometric applications and challenges in the development of therapeutic antibodies in immuno-oncology
  publication-title: Curr. Pharm. Rep.
  doi: 10.1007/s40495-018-0142-5
– volume: 46
  start-page: 1485
  year: 2019
  end-page: 1494
  ident: CR25
  article-title: Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma
  publication-title: Eur. J. Nucl. Med Mol. Imaging
  doi: 10.1007/s00259-019-04307-6
– volume: 37
  start-page: 250
  year: 2010
  end-page: 259
  ident: CR46
  article-title: p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-009-1263-1
– volume: 329
  start-page: 856
  year: 2010
  end-page: 861
  ident: CR49
  article-title: Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
  publication-title: Science
  doi: 10.1126/science.1187659
– volume: 65
  start-page: 103252
  year: 2021
  ident: CR35
  article-title: A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103252
– volume: 14
  start-page: e1002435
  year: 2017
  ident: CR10
  article-title: Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: results of a phase 1 randomized trial
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1002435
– volume: 11
  start-page: 932
  year: 2018
  end-page: 946
  ident: CR7
  article-title: Early treatment of SIV+ macaques with an alpha4beta7 mAb alters virus distribution and preserves CD4(+) T cells in later stages of infection
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2017.112
– volume: 15
  start-page: e1007619
  year: 2019
  ident: CR34
  article-title: Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1007619
– volume: 10
  start-page: 2077
  year: 2019
  ident: CR8
  article-title: Seeing is believing: nuclear imaging of HIV persistence
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2019.02077
– volume: 7
  start-page: 319ra206
  year: 2015
  ident: CR11
  article-title: Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aad5752
– ident: CR24
– volume: 43
  start-page: 65
  year: 2006
  end-page: 68
  ident: CR28
  article-title: Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals
  publication-title: J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/01.qai.0000230524.71717.14
– volume: 278
  start-page: 1295
  year: 1997
  ident: 28727_CR2
  publication-title: Science
  doi: 10.1126/science.278.5341.1295
– volume: 202
  start-page: 595
  year: 2010
  ident: 28727_CR18
  publication-title: J. Infect. Dis.
  doi: 10.1086/654816
– volume: 22
  start-page: 105
  year: 2020
  ident: 28727_CR48
  publication-title: Mol. Imaging Biol.
  doi: 10.1007/s11307-019-01363-0
– volume: 10
  start-page: 2077
  year: 2019
  ident: 28727_CR8
  publication-title: Front Immunol.
  doi: 10.3389/fimmu.2019.02077
– volume: 202
  start-page: 1553
  year: 2010
  ident: 28727_CR31
  publication-title: J. Infect. Dis.
  doi: 10.1086/656722
– volume: 120
  start-page: 3787
  year: 2020
  ident: 28727_CR37
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.9b00738
– volume: 4
  start-page: 285
  year: 2018
  ident: 28727_CR44
  publication-title: Curr. Pharm. Rep.
  doi: 10.1007/s40495-018-0142-5
– volume: 21
  start-page: 565
  year: 2007
  ident: 28727_CR27
  publication-title: Aids
  doi: 10.1097/QAD.0b013e3280117204
– volume: 23
  start-page: 1271
  year: 2017
  ident: 28727_CR4
  publication-title: Nat. Med.
  doi: 10.1038/nm.4411
– volume: 56
  start-page: 1150
  year: 2015
  ident: 28727_CR21
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.115.155309
– volume: 7
  start-page: 319ra206
  year: 2015
  ident: 28727_CR11
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aad5752
– volume: 15
  start-page: e1007619
  year: 2019
  ident: 28727_CR34
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1007619
– volume: 111
  start-page: 13151
  year: 2014
  ident: 28727_CR14
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1414148111
– volume: 58
  start-page: 1770
  year: 2017
  ident: 28727_CR23
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.117.190736
– volume: 112
  start-page: E1126
  year: 2015
  ident: 28727_CR36
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1414926112
– volume: 61
  start-page: 727
  year: 2018
  ident: 28727_CR39
  publication-title: J. Label. Comp. Radiopharm.
  doi: 10.1002/jlcr.3605
– volume: 43
  start-page: 65
  year: 2006
  ident: 28727_CR28
  publication-title: J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/01.qai.0000230524.71717.14
– volume: 60
  start-page: 1825
  year: 2019
  ident: 28727_CR38
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.118.224568
– volume: 86
  start-page: 7588
  year: 2012
  ident: 28727_CR17
  publication-title: J. Virol.
  doi: 10.1128/JVI.00734-12
– volume: 13
  start-page: e0193832
  year: 2018
  ident: 28727_CR47
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0193832
– volume: 26
  start-page: 1
  year: 2001
  ident: 28727_CR30
  publication-title: J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/00126334-200101010-00001
– volume: 375
  start-page: 2037
  year: 2016
  ident: 28727_CR9
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1608243
– volume: 54
  start-page: 677
  year: 2013
  ident: 28727_CR26
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.112.108530
– ident: 28727_CR5
  doi: 10.1172/JCI134815
– volume: 99
  start-page: 8031
  year: 2002
  ident: 28727_CR40
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.122696599
– ident: 28727_CR16
  doi: 10.3791/52521
– ident: 28727_CR50
  doi: 10.7326/M14-1027
– volume: 329
  start-page: 856
  year: 2010
  ident: 28727_CR49
  publication-title: Science
  doi: 10.1126/science.1187659
– ident: 28727_CR15
– volume: 37
  start-page: 250
  year: 2010
  ident: 28727_CR46
  publication-title: Eur. J. Nucl. Med. Mol. Imaging
  doi: 10.1007/s00259-009-1263-1
– volume: 213
  start-page: 766
  year: 2016
  ident: 28727_CR51
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiv504
– volume: 76
  start-page: 3522
  year: 2002
  ident: 28727_CR41
  publication-title: J. Virol.
  doi: 10.1128/JVI.76.7.3522-3533.2002
– volume: 5
  start-page: 739
  year: 2010
  ident: 28727_CR45
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2010.13
– ident: 28727_CR33
  doi: 10.1128/JVI.01344-18
– ident: 28727_CR32
  doi: 10.7554/eLife.46916
– volume: 1
  start-page: 382
  year: 2008
  ident: 28727_CR29
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2008.23
– volume: 9
  start-page: 727
  year: 2003
  ident: 28727_CR3
  publication-title: Nat. Med.
  doi: 10.1038/nm880
– volume: 6
  year: 2016
  ident: 28727_CR20
  publication-title: EJNMMI Res.
  doi: 10.1186/s13550-016-0208-5
– volume: 31
  start-page: 496
  year: 2010
  ident: 28727_CR19
  publication-title: Semin. Ultrasound CT MR
  doi: 10.1053/j.sult.2010.10.001
– volume: 329
  start-page: 811
  year: 2010
  ident: 28727_CR12
  publication-title: Science
  doi: 10.1126/science.1192819
– volume: 85
  start-page: 8954
  year: 2011
  ident: 28727_CR13
  publication-title: J. Virol.
  doi: 10.1128/JVI.00754-11
– volume: 6
  start-page: 576
  year: 2017
  ident: 28727_CR43
  publication-title: CPT Pharmacomet. Syst. Pharm.
  doi: 10.1002/psp4.12224
– volume: 14
  start-page: e1002435
  year: 2017
  ident: 28727_CR10
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1002435
– volume: 23
  start-page: 1943
  year: 2015
  ident: 28727_CR42
  publication-title: Structure
  doi: 10.1016/j.str.2015.07.020
– ident: 28727_CR24
  doi: 10.2967/jnumed.117.207670
– volume: 11
  start-page: 932
  year: 2018
  ident: 28727_CR7
  publication-title: Mucosal Immunol.
  doi: 10.1038/mi.2017.112
– volume: 43
  start-page: 715
  year: 2018
  ident: 28727_CR22
  publication-title: Clin. Nucl. Med.
  doi: 10.1097/RLU.0000000000002229
– volume: 46
  start-page: 1485
  year: 2019
  ident: 28727_CR25
  publication-title: Eur. J. Nucl. Med Mol. Imaging
  doi: 10.1007/s00259-019-04307-6
– volume: 12
  start-page: 427
  year: 2015
  ident: 28727_CR6
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3320
– volume: 387
  start-page: 183
  year: 1997
  ident: 28727_CR1
  publication-title: Nature
  doi: 10.1038/387183a0
– volume: 65
  start-page: 103252
  year: 2021
  ident: 28727_CR35
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103252
SSID ssj0000391844
Score 2.5102544
Snippet A major obstacle to achieving long-term antiretroviral (ART) free remission or functional cure of HIV infection is the presence of persistently infected cells...
Here, the authors apply positron emission tomography (PET) imaging to visualize HIV tissue-wide burden in infected individuals using a radiolabeled broadly...
SourceID doaj
pubmedcentral
proquest
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1219
SubjectTerms 13/1
13/31
45/22
45/23
45/90
45/91
59/57
59/78
631/250/255/1901
692/308/575
692/699/255/1901
Antibodies
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Biopsy
CD4 antigen
HIV
Human immunodeficiency virus
Humanities and Social Sciences
Infections
Infectious diseases
Lymph nodes
Lymphatic system
Lymphocytes
Lymphocytes T
Medical imaging
multidisciplinary
Neutralizing
Positron emission
Positron emission tomography
Protein expression
Proteins
Remission
Science
Science (multidisciplinary)
Therapeutic applications
Tissues
Tomography
Transcription
Viremia
Zirconium isotopes
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1daxQxMEhB8EX8xNUqEXzT0N0km4_HWnqcgiLSluJL2NkkeqXsyvXu4fz1nWT3zm5BffEtbGbZJPO9M5kh5A0oD6aNLdMVCCat8gxqKZhqhYqoc2LI4YJPn9X8VH48r89vtPpKOWFDeeDh4A4kb6oqoOFd-iih4oDStJFSxMZEHVpI0re05Q1nKstgYdF1keMtmVKYgyuZZUJKXkcngWtWTzRRLtg_sTJv50jeCpRm_TN7QO6PhiM9HBb8kNwJ3SNyd2gluXlMLmYLtOPYomO56x5dpHsf_ZfjExzlRkS0j3T-4YxVdJt_1dGU9P6dGvttyZAYUAF5evb1qKwoLPvGX25oF9b5T8ivBIc4WEDvN0_I6ez45GjOxj4KrK0rsWJRIKdqNLSEknh81ljQIJsy4riVMqBLFoVP8VTBIXDPRQ06eIBUOSa0XDwle13fhWeENlJxr8pW62BlHYRpSjAaFAiI3HJTkGp7pq4di4ynXheXLge7hXEDHhziwWU8uLogb3fv_BxKbPwV-n1C1Q4ylcfOD5Bo3Eg07l9EU5D9LaLdyLNXjisUtui_Vbogr3fTyG0phNJ0oV9nmHw3WdiC6AmBTBY0nekWP3LdbmNRnta4g3dbUvr98T9v-Pn_2PALco8n0k_Jc3af7K2W6_ASrakVvMqMcw0_eRmv
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1La9swWHQpg13GnsxrNzTYbRO1JVmSD2OsJSEbLJTSlrKLsF5dRrHbNDlkv36fFDvFhfUmrM9Y8veUvhdCH41wRtlgiSwMI7wSjpiSMyIsEwF0TvDJXfBzJqZn_MdFebGDZn0uTAyr7GViEtSutfGO_IAKYAWwrgv59fqGxK5R0bvat9Cou9YK7ksqMfYI7YJILvMR2j0cz45PtrcusR664rzLnsmZOrjlSVbEoHY4PFBJyoGGSoX8B9bn_djJew7UpJcmz9DTzqDE3zYU8Bzt-OYFerxpMbl-if5M5mDfkXlDUjc-PI_5IO3x-BRGqUERbgOefj8nBe7jshocg-Evsap-LQgQCSgmh89PjvICm0Vbu6s1bvwq3ZD8jXCAm7lp3foVOpuMT4-mpOuvQGxZsCUJDDhYggHGBDdcVqoy0vA6DzC2nHs4qgXmop-VUeOpo6w00jtjYkUZbyl7jUZN2_g3CNdcUCdyK6WveOmZqnOjpBGGmUArqjJU9P9U2674eOyBcaWTE5wpvcGDBjzohAddZujT9p3rTemNB6EPI6q2kLFsdnrQLi51x4Wa07ooPJziche4KSjsuqg5Z6FWQXprMrTfI1p3vHyr7ygvQx-208CF0bVSN75dJZiUs8yqDMkBgQwWNJxp5r9TPW9VgZwtYQefe1K6-_j_N_z24bXuoSc0EnUMl6v20Wi5WPl3YD8tzfuOKf4BkW0XfA
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1di9QwMJwngi_iJ1ZPieCbBpuPJumjLresgiJydxy-hE6TnCtHK3u7D-uvd5JtV3qo4FtoJjTJzGQmmS9CXoL2YNvYMsNBMlVrz6BSkulW6ogyJ4ZsLvj4SS9O1Yfz6vyAiDEWJjvt55SW-ZgevcPeXKnM0sn3HHV8YVh1g9y0RlaJqmd6tn9XSRnPrVJDfEwp7R-GTmRQTtU_0S-ve0deM5FmyTO_S-4MKiN9u5vkPXIQuvvk1q6I5PYB-T5fogbHlh3L9fboMkV89J-PT7CVSxDRPtLF-zPG6eh51dHk7n5Bbf11xZAMUPR4evZlVnIKq77xl1vahU1-A_mZ4HD3l9D77UNyOj8-mS3YUEGBtRWXaxYl8qhBFUtqBcrUtgYDqikjtlulAl7GovTJkioFBOGFrMAED5ByxoRWyEfksOu78JjQRmnhddkaE2pVBWmbEqwBDRKiqIUtCB_31LVDevFU5eLSZTO3tG6HB4d4cBkPrirIq_2YH7vkGv-EfpdQtYdMibHzh3514QZCcUo0nAe8p5U-KuACV80bpWRsbDShhYIcjYh2A7deOaHxmMWbGzcFebHvRj5LxpOmC_0mw-SoZFkXxEwIZDKhaU-3_JYzdtsaT9IKV_B6JKXfP__7gp_8H_hTclskIk8OcvUROVyvNuEZakxreJ5Z5BenyQ6z
  priority: 102
  providerName: Springer Nature
Title First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody
URI https://link.springer.com/article/10.1038/s41467-022-28727-5
https://www.proquest.com/docview/2637648717
https://www.proquest.com/docview/2638022039
https://pubmed.ncbi.nlm.nih.gov/PMC8907355
https://doaj.org/article/42a11e0860df4b12b471a443fa8f7ecb
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1di9QwMNwHgi_iJ1bPJYJvGt0maZI-iOwtu64LHsd5eyy-lKZN7ipLq71dcP31TtJ2pccp-NKGZEKbzEwyk5nMIPRKi1yrzGZEhpoRHouc6IgzIjImLOw51nhzwecTMVvw-TJa7qEu3VE7gde3qnYun9SiXr39-WP7ARj-fXNlXL275p7dnV86yP9UkmgfHXp7kXPla8V9vzKzGBQa3t6dub1rb3_yYfx7sudNz8kb5lO_K03vo3utOIlHDf4foD1TPkR3mgST20fo27QA6Y4UJfG5-HDhboNUp5NzKPn0RLiyePbpgoS488oqsXOFv8Qq_loTIBHYlnJ8cTYehljXVZqvtrg0G38-8svBAWYKXeXbx2gxnZyPZ6TNrkCyKGRrYhnwrwTxiwmuuYxVrKXm6dBCOePcgKJmWe6srIxqQ3PKIi1NrrWLJ2Myyp6gg7IqzVOEUy5oLoaZlCbmkWEqHWoltdBMWxpTFaCwm9Mka0OPuwwYq8SbwJlKGjwkgIfE4yGJAvR61-d7E3jjn9DHDlU7SBc021dU9WXS8mDCaRqGBnS4YW65DimMOkw5ZzZVVppMB-ioQ3TSEWJCBSzBoNWFMkAvd83Ag86wkpam2ngYf2OZxQGSPQLp_VC_pSyufDRvFcMqG8EI3nSk9Ofjfx_ws_8Df47uUkfkznkuPkIH63pjXoA0tdYDtC-XEp5q-nGADkej-Zc5vI8nJ6dnUDsW44E_pxh4VvoNv0YfEQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTgheEFcRGGAkeAJrie3EzsOE2GjVsq2apm6aePHi2B5FUzJ6ESo_jt_GsZt06iT2treocdQ45-5zzncQeq8zo2XpSiISzQjPM0N0yhnJSpY5sDnOhnTB4TDrn_BvZ-nZBvrb9sL4sspWJwZFberSn5Fv0wxEAbzrRHy--kX81CifXW1HaBTNaAWzEyDGmsaOfbv4DSHcdGfwFej9gdJed7TXJ82UAVKmCZsRBwE92E3qkdQ1F7nMtdC8iB1cl5xbCFgcMz7byKi21FCWamGN1h5XxZYe-ABMwCb3BygdtLnbHR4dr055PP665Lzp1omZ3J7yoJt8ET0EK1SQdM0ihsEBa97uzVrNGwnbYAd7j9DDxoHFX5Yc9xht2OoJurccabl4in72xuBPknFFwvQ_PPb9J_VRdwRXYSASrh3uD05Jgts6sAr74vsLLPPvEwJMCYbQ4NPjvTjBelIX5nKBKzsPJzJ__DrghbGuzeIZOrmTL_0cdaq6si8QLnhGTRaXQticp5bJItZS6Ewz7WhOZYSS9puqsgE79zM3LlVIujOplnRQQAcV6KDSCH1cPXO1hPq4dfWuJ9VqpYfpDj_UkwvVSL3itEgSC1FjbBzXCYVdJwXnzBXSCVvqCG21hFaN7piqa06P0LvVbZB6n8opKlvPw5rQI83yCIk1Bll7ofU71fhHwA-XOej1FHbwqWWl6z___4Zf3v6ub9H9_ujwQB0Mhvuv0APqGdyX6uVbqDObzO1r8N1m-k0jIBid37VM_gNhxlKV
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIhAXxFOEFjASnMDaxHZi54AQtF3tUqgq1FYrLiaO7ZKqSso-hJafxq9j7CRbbSV66y1KHCX2vD3j-RB6rTOjZelKIhLNCM8zQ3TKGclKljmwOc6GdMHXg2x0zD9P0skG-tufhfFllb1ODIraNKXfIx_QDEQBvOtEDFxXFnG4O_xw8Yt4BCmfae3hNFoW2bfL3xC-zd6Pd4HWbygd7h3tjEiHMEDKNGFz4iCYB5tJfRd1zUUucy00L2IH1yXnFoIVx4zPNDKqLTWUpVpYo7XvqWJL3_QA1P8twTj3sBFiIlb7O77zuuS8O6cTMzmY8aCVfPk8hClUkHTNFgbIgDU_92qV5pVUbbCAw_voXue64o8trz1AG7Z-iG63YJbLR-hsWIEnSaqaBNw_XPmTJ83h3hFcBSgk3Dg8Gp-QBPcVYDX2ZfenWObfpwTYEUygwSffduIE62lTmPMlru0i7MX88eOACyrdmOVjdHwj6_wEbdZNbZ8iXPCMmiwuhbA5Ty2TRayl0Jlm2tGcyggl_Zqqsmtz7tE2zlVItzOpWjoooIMKdFBphN6u3rlom3xcO_qTJ9VqpG_QHW4001PVybvitEgSC_FibBzXCYVZJwXnzBXSCVvqCG33hFad1pipSx6P0KvVY5B3n8QpatsswphwOprlERJrDLL2Q-tP6upn6Bwuc9DoKczgXc9Klx___4SfXf-vL9EdkET1ZXywv4XuUs_fvkYv30ab8-nCPgenba5fBOnA6MdNi-M_EQJQMQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=First-in-human+immunoPET+imaging+of+HIV-1+infection+using+89Zr-labeled+VRC01+broadly+neutralizing+antibody&rft.jtitle=Nature+communications&rft.au=Beckford-Vera%2C+Denis+R.&rft.au=Flavell%2C+Robert+R.&rft.au=Seo%2C+Youngho&rft.au=Martinez-Ortiz%2C+Enrique&rft.date=2022-03-09&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-1723&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-022-28727-5&rft.externalDocID=10_1038_s41467_022_28727_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon